Success Metrics

Clinical Success Rate

71.4%

Based on 5 completed trials

Completion Rate

71%(5/7)

Active Trials

0(0%)

Results Posted

140%(7 trials)

Terminated

2(29%)

Phase Distribution

Ph phase_3

57%

Ph phase_2

43%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 2Efficacy & side effects

3(42.9%)

Phase 3Large-scale testing

4(57.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Terminated(2)

Detailed Status

Completed5

Terminated2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

71.4%

Most Advanced

Phase 3

Trials by Phase

Phase 23 (42.9%)

Phase 34 (57.1%)

Trials by Status

terminated229%

completed571%

Recent Activity

0 active trials

Showing 5 of 7

completedphase_3

A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)

NCT01760447

completedphase_3

Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)

NCT01485614

completedphase_3

A Study to Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)

NCT01717313

terminatedphase_2

A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009)

NCT00868790

completedphase_2

A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)

NCT01217073

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT01760447Phase 3

A Pooled Analysis of the Safety and Efficacy of MK-0431A and MK-0431A XR in Pediatric Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Therapy (Alone or in Combination With Insulin) (MK-0431A-170/MK-0431A-289)

Completed

NCT01485614Phase 3

Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)

Completed

NCT01717313Phase 3

A Study to Assess the Safety and Efficacy of Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (T2DM) and Inadequate Glycemic Control (MK-3102-011)

Completed

NCT00868790Phase 2

A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009)

Terminated

NCT01217073Phase 2

A Dose-Range Finding Study in Participants With Type 2 Diabetes (MK-3102-006)

Completed

NCT01958671Phase 3

A Study of the Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)

Completed

NCT00479466Phase 2

Dose-Range Finding Study for MK0893 (0893-008)

Terminated

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7